Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

Integer Technologies Launches Integer Constellation Labs 

August 26, 2026

Automatic Trap Company Expands Poison-Free Ground Squirrel Control as California Pest Professionals Adapt to Rodenticide Restrictions

August 26, 2026

SkinHealth Systems Launches Hydrafacial Impact to Help Providers Accelerate Practice Growth

August 26, 2026

Purecore Provides Corporate Update Highlighting Execution Across Uranium, Copper and Capital Markets

August 26, 2026

Medication Adherence Global Market Report 2026-2035: Profiles Medtronic, Roche, Insulet, Ypsomed, and 13 Other Key Players

August 26, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » Lumin Health Appoints Matthew Mosquera, MD, MS, as Regional Medical Director and Site Director of Lumin Cambridge
Press Release

Lumin Health Appoints Matthew Mosquera, MD, MS, as Regional Medical Director and Site Director of Lumin Cambridge

By News RoomApril 7, 20262 Mins Read
Lumin Health Appoints Matthew Mosquera, MD, MS, as Regional Medical Director and Site Director of Lumin Cambridge
Share
Facebook Twitter LinkedIn Pinterest Email

BOSTON, April 07, 2026 (GLOBE NEWSWIRE) — Lumin Health, a physician-led provider of interventional behavioral health care offering SPRAVATO® (esketamine) nasal spray and ketamine-based therapies in a purpose-built outpatient setting, today announced the appointment of Matthew Mosquera, MD, MS, as Regional Medical Director and Site Director of Lumin Health Cambridge, where he leads the team serving patients across Cambridge and Greater Boston.

In his role, Dr. Mosquera will oversee clinical quality and consistency across Lumin Health’s Massachusetts clinics, with a focus on standardized protocols, clinician support, and coordination with referring providers. At Lumin Health’s Cambridge location, he will focus on building a patient-centered care environment designed for people navigating treatment-resistant depression and complex mood disorders.

As demand for ketamine and esketamine treatment has grown, care has often gravitated toward hospital-based settings or at-home models. Lumin Health is designed to provide clear clinical structure and monitoring while preserving patient agency and prioritizing human support at critical moments.

“People often arrive at Lumin Health worn down by years of trying to get better and losing confidence that anything will truly change,” said Dr. Mosquera. “We take that seriously. Our role is to restore trust and optimism through rigorous care that still feels human. We pair strong screening and supervision with a calm environment and real-time support.”

Dr. Mosquera is a Harvard-trained psychiatrist, double board-certified in general and addiction psychiatry, an attending psychiatrist at McLean Hospital, and faculty at Harvard Medical School. He previously served as a medical director at McLean Hospital and has published on physician well-being and the stress of medical training.

He earned his MD from Northwestern University Feinberg School of Medicine and a master’s degree in complementary and alternative medicine from Georgetown University, which informs his whole-person approach that integrates evidence-based psychiatry with mindfulness and breathwork.

About Lumin Health
Lumin Health is a physician-led provider of interventional behavioral health care, delivering medically supervised SPRAVATO® and ketamine-based treatment in a purpose-built outpatient setting and partnering with community providers to expand responsible access to effective care.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/cb31fc23-dea3-476e-971b-6265973b0739

            
Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

Integer Technologies Launches Integer Constellation Labs 

Automatic Trap Company Expands Poison-Free Ground Squirrel Control as California Pest Professionals Adapt to Rodenticide Restrictions

SkinHealth Systems Launches Hydrafacial Impact to Help Providers Accelerate Practice Growth

Purecore Provides Corporate Update Highlighting Execution Across Uranium, Copper and Capital Markets

Medication Adherence Global Market Report 2026-2035: Profiles Medtronic, Roche, Insulet, Ypsomed, and 13 Other Key Players

BTT Medical Institute Launches First-in-Human Safety Clinical Trial Evaluating Induced Hyperthermia with the Computerized Brain-Guided Abreu BTT 700 Temperature Management System (TMS) Inspired by the Nobel Prize-recognized Malarial Fever Therapy

AWS and NVIDIA to Deliver 2 Million Additional GPUs and Next-Generation Infrastructure for Agentic and Physical AI

Novonesis Expands U.S. Workforce Development Efforts to Build the Next Generation of Biomanufacturing Talent

World’s-First Battery-Powered Self-Unloading Bulk Carrier Now Operating in South Australia

Editors Picks

Automatic Trap Company Expands Poison-Free Ground Squirrel Control as California Pest Professionals Adapt to Rodenticide Restrictions

August 26, 2026

SkinHealth Systems Launches Hydrafacial Impact to Help Providers Accelerate Practice Growth

August 26, 2026

Purecore Provides Corporate Update Highlighting Execution Across Uranium, Copper and Capital Markets

August 26, 2026

Medication Adherence Global Market Report 2026-2035: Profiles Medtronic, Roche, Insulet, Ypsomed, and 13 Other Key Players

August 26, 2026

Latest News

Pair accused of murder in 2023 shooting death of Ontario teen: police

August 26, 2026

Saskatchewan to tax U.S. booze, but premier says potash and oil are off the table

August 26, 2026

BTT Medical Institute Launches First-in-Human Safety Clinical Trial Evaluating Induced Hyperthermia with the Computerized Brain-Guided Abreu BTT 700 Temperature Management System (TMS) Inspired by the Nobel Prize-recognized Malarial Fever Therapy

August 26, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version